107 related articles for article (PubMed ID: 3909239)
1. Irradiation therapy with multiple small fractions per day in urinary bladder cancer.
Edsmyr F; Andersson L; Esposti PL; Littbrand B; Nilsson B
Radiother Oncol; 1985 Nov; 4(3):197-203. PubMed ID: 3909239
[TBL] [Abstract][Full Text] [Related]
2. Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial.
Näslund I; Nilsson B; Littbrand B
Acta Oncol; 1994; 33(4):397-402. PubMed ID: 8018372
[TBL] [Abstract][Full Text] [Related]
3. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group.
Cox JD; Guse C; Asbell S; Rubin P; Sause WT
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1331-6. PubMed ID: 3058657
[TBL] [Abstract][Full Text] [Related]
4. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
5. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer.
Quilty PM; Duncan W; Kerr GR
Clin Radiol; 1985 Nov; 36(6):615-8. PubMed ID: 4064546
[TBL] [Abstract][Full Text] [Related]
6. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
[TBL] [Abstract][Full Text] [Related]
8. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
9. [Results of radiotherapeutic optimization within the scope of combined operative-radiologic therapy of urinary bladder cancer].
Kob D; Kloetzer KH; Kriester A; Arndt J; Bockhorn V; Möller A; Bothor C; Pirlich W
Z Urol Nephrol; 1985 Oct; 78(10):545-50. PubMed ID: 3907198
[TBL] [Abstract][Full Text] [Related]
10. Radical irradiation of T2 and T3 bladder carcinoma. A retrospective investigation.
Fosså SD; Ous S; Knudsen OS
Acta Radiol Oncol; 1985; 24(6):497-501. PubMed ID: 3006439
[TBL] [Abstract][Full Text] [Related]
11. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.
Yavuz AA; Yavuz MN; Ozgur GK; Colak F; Ozyavuz R; Cimsitoglu E; Ilis E
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):734-45. PubMed ID: 12788179
[TBL] [Abstract][Full Text] [Related]
12. [Concurrent chemotherapy and hyperfractionated radiotherapy for non-operable carcinoma of the bladder].
Schmitt T; Armand C; Mille D; Favrel-Tchakamian V; Gilloz A
Cancer Radiother; 1998 Apr; 2 Suppl 1():82s-84s. PubMed ID: 9749085
[TBL] [Abstract][Full Text] [Related]
13. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
Wang CC; Nakfoor BM; Spiro IJ; Martins P
Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
[TBL] [Abstract][Full Text] [Related]
14. An analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer.
Duncan W; Williams JR; Kerr GR; Arnott SJ; Quilty PM; Rodger A; MacDougall RH; Jack WJ
Int J Radiat Oncol Biol Phys; 1986 Dec; 12(12):2085-92. PubMed ID: 3539897
[TBL] [Abstract][Full Text] [Related]
15. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
16. Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model.
Jereczek-Fossa B; Jassem J; Nowak R; Badzio A
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):329-38. PubMed ID: 9607348
[TBL] [Abstract][Full Text] [Related]
17. [Results of percutaneous radiotherapy of bladder cancer using 1 and 2 series of irradiation].
Kob D; Arndt J; Kriester A; Schwenk M; Kloetzer KH
Strahlentherapie; 1985 Nov; 161(11):673-7. PubMed ID: 3907021
[TBL] [Abstract][Full Text] [Related]
18. A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder.
Moonen L; van der Voet H; Horenblas S; Bartelink H
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):537-42. PubMed ID: 9112450
[TBL] [Abstract][Full Text] [Related]
19. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
20. Organ-sparing treatment in muscle-invasive bladder cancer.
Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
